ÎÚÑ»´«Ã½

About ASH Annual Meeting Abstracts

Abstracts submitted for oral and poster presentation at the ASH annual meeting represent important, novel research in the field and are considered the best of the thousands of abstracts submitted. Typically, more than 7,000 scientific abstracts are submitted each year, and more than 5,000 abstracts are accepted for oral and poster presentations through an extensive peer review process.

Abstract categories are reviewed and updated annually to respond to trends and cover new areas. This year, updates include

• The renumbering of categories (particularly those in the 600 and 900 groupings)
• The discontinuation of two categories (731. Autologous Transplantation, and 705. Cellular Immunotherapies: Commercial and Late Stage)
• The addition of several new categories (909. ÎÚÑ»´«Ã½, Communication, and Workforce, 628. Aggressive Lymphomas: Cellular Therapies, and 655. Multiple Myeloma: Cellular therapies)
• The splitting of several categories (including several in thrombosis and homeostasis, clinical lymphomas, and health services, quality improvement and outcomes research).

View the full list of abstract categories.

The Plenary Scientific Session, which includes the top six abstracts as selected by the Program Committee, is traditionally a highlight of the annual meeting program.

Key Dates and Deadlines

Related Content